Family history of pancreatic cancer in a high-risk cancer clinic: Implications for risk assessment

Journal of Genetic Counseling

Volumn 17, Issue 4, 2008, Pages 365-372

  Hall, Michael J ^a,b,d   Dignam, James J ^c   Olopade, Olufunmilayo I ^c  

^a Mailman School of Public Health ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

BRCA1 2; HBOS; Pancreatic cancer; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; BRCA2 ONCOGENE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; HEREDITARY BREAST OVARIAN SYNDROME; HIGH RISK POPULATION; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVARY CANCER; PANCREAS CANCER; PEDIGREE; RELATIVE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PEDIGREE; RISK ASSESSMENT;

EID: 48449083823     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-008-9154-3     Document Type: Article

References (38)

1. M. Aarnio R. Sankila E. Pukkala R. Salovaara L. A. Aaltonen A. de la Chapelle 1999 Cancer risk in mutation carriers of DNA-mismatch-repair genes International Journal of Cancer 81 214 218
2. anonymous 1999 Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium Journal of the National Cancer Institute 91 1310 1316
3. D. A. Berry E. S. Iversen Jr. D. F. Gudbjartsson E. H. Hiller J. E. Garber B. N. Peshkin 2002 BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes Journal of Clinical Oncology 20 2701 2712
4. W. Burke M. Daly J. Garber J. Botkin M. J. Khan P. Lynch 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer genetics studies consortium JAMA 277 997 1003
5. F. J. Couch M. L. DeShano M. A. Blackwood K. Calzone J. Stopfer L. Campeau 1997 BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer New England Journal of Medicine 336 1409 1415
6. F. J. Couch M. R. Johnson K. G. Rabe K. Brune M. de Andrade M. Goggins 2007 The prevalence of BRCA2 mutations in familial pancreatic cancer Cancer Epidemiology, Biomarkers & Prevention 6 342 346
7. M. Epplein K. P. Koon S. D. Ramsey J. D. Potter 2005 Genetic services for familial cancer patients: A follow-up survey of National Cancer Institute Cancer Centers Journal of Clinical Oncology 23 4713 4718
8. D. G. Evans D. M. Eccles N. Rahman K. Young M. Bulman E. Amir 2004 A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO Journal of Medical Genetics 41 474 480
9. P. Hopwood C. J. van Asperen G. Borreani P. Bourret M. Decruyenaere S. Dishon 2003 Cancer genetic services provision: A comparison of Seven European Centres Community Genetics 6 192 205
10. D. G. Jagelman J. J. DeCosse H. J. Bussey 1988 Upper gastrointestinal cancer in familial adenomatous polyposis Lancet 1 1149 1151
11. A. Jemal R. Siegel E. Ward T. Murray J. Xu M. J. Thun 2007 Cancer statistics, 2007 CA Cancer Journal for Clinicians 57 43 66
12. A. P. Klein T. H. Beaty J. E. Bailey-Wilson K. A. Brune R. H. Hruban G. M. Petersen 2002 Evidence for a major gene influencing risk of pancreatic cancer Genetic Epidemiology 23 133 149
13. A. P. Klein K. A. Brune G. M. Petersen M. Goggins A. C. Tersmette G. J. Offerhaus 2004 Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds Cancer Research 64 2634 2638
14. G. Lal G. Liu B. Schmocker P. Kaurah H. Ozcelik S. A. Narod 2000 Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations Cancer Research 60 409 416
15. N. M. Lindor G. M. Petersen D. W. Hadley A. Y. Kinney S. Miesfeldt K. H. Lu 2005 Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review JAMA 27 1507 1517
16. J. Lubinski C. M. Phelan P. Ghadirian H. T. Lynch J. Garber B. Weber 2004 Cancer variation associated with the position of the mutation in the BRCA2 gene Familial Cancer 3 1 10
17. H. T. Lynch R. E. Brand C. A. Deters T. G. Shaw J. F. Lynch 2001 Hereditary pancreatic cancer Pancreatology 1 466 471
18. H. T. Lynch R. E. Brand D. Hogg C. A. Deters R. M. Fusaro J. F. Lynch 2002 Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical multiple mole melanoma-pancreatic carcinoma syndrome Cancer 94 84 96
19. H. J. Murff D. R. Spigel S. Syngal 2004 Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history JAMA 292 1480 1489
20. K. M. Murphy K. A. Brune C. Griffin J. E. Sollenberger G. M. Petersen R. Bansal 2002 Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17% Cancer Research 62 3789 3793
21. H. D. Nelson L. H. Huffman R. Fu E. L. Harris 2005 Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force Annals of Internal Medicine 143 355 379
22. H. Ozcelik B. Schmocker N. Di Nicola X. H. Shi B. Langer M. Moore 1997 Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nature Genetics 16 17 18
23. M. R. Palomares B. Paz J. N. Weitzel 2005 Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice Journal of Clinical Oncology 23 3165 3166
24. G. M. Petersen M. de Andrade M. Goggins R. H. Hruban M. Bondy J. F. Korczak 2006 Pancreatic cancer genetic epidemiology consortium Cancer Epidemiology, Biomarkers & Prevention 15 704 710
25. K. L. Pogue-Geile R. Chen M. P. Bronner T. Crnogorac-Jurcevic K. W. Moyes S. Dowen 2006 Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med 3 e516
26. T. R. Rebbeck T. Friebel H. T. Lynch S. L. Neuhausen L. van 't Veer J. E. Garber 2004 Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group Journal of Clinical Oncology 22 1055 1062
27. T. R. Rebbeck A. M. Levin A. Eisen C. Snyder P. Watson L. Cannon-Albright 1999 Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers Journal of the National Cancer Institute 91 1475 1479
28. S. J. Rulyak T. A. Brentnall 2001 Inherited pancreatic cancer: Surveillance and treatment strategies for affected families Pancreatology 1 477 485
29. S. J. Rulyak A. B. Lowenfels P. Maisonneuve T. A. Brentnall 2003 Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds Gastroenterology 124 1292 1299
30. D. L. Sackett 1979 Bias in analytic research Journal of Chronic Diseases 32 51 63
31. D. Thompson D. F. Easton Breast Cancer Linkage Consortium 2002 Cancer incidence in BRCA1 mutation carriers Journal of the National Cancer Institute 94 1358 1365
32. A. Umar C. R. Boland J. P. Terdiman S. Syngal A. de la Chapelle J. Ruschoff 2004 Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability Journal of the National Cancer Institute 96 261 268
33. C. J. van Asperen R. M. Brohet E. J. Meijers-Heijboer N. Hoogerbrugge S. Verhoef H. F. Vasen 2005 Cancer risks in BRCA2 families: Estimates for sites other than breast and ovary Journal of Medical Genetics 42 711 719
34. H. F. Vasen P. Watson J. P. Mecklin H. T. Lynch 1999 New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC Gastroenterology 116 1453 1456
35. S. Wacholder 2004 Bias in intervention studies that enroll patients from high-risk clinics Journal of the National Cancer Institute 96 1204 1207
36. J. N. Weitzel V. I. Lagos C. A. Cullinane P. J. Gambol J. O. Culver K. R. Blazer 2007 Limited family structure and BRCA gene mutation status in single cases of breast cancer JAMA 297 2587 2595
37. M. White O. I. Olopade 2000 Cancer risk assessment: Toward a primary prevention of breast and ovarian cancer Oncol Econ 1 40 45
38. A. Ziogas H. Anton-Culver 2003 Validation of family history data in cancer family registries American Journal of Preventive Medicine 24 190 198